Ligand validation:4DM3

RCO: RESORCINOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4DM3_RCO_B_302	7%	75%	0.301	0.761	0.47	0.48	-	-	7	0	100%	0.48
4DM3_RCO_A_2002	4%	78%	0.401	0.785	0.35	0.53	-	-	6	0	100%	0.33
2OM0_RCO_U_704	99%	56%	0.051	0.987	1.15	0.53	1	-	0	0	100%	1
2OLY_RCO_C_504	98%	70%	0.061	0.984	0.83	0.32	-	-	0	0	100%	1
2OM1_RCO_G_1002	98%	65%	0.062	0.984	0.83	0.51	-	-	0	0	100%	1
4AJX_RCO_J_1029	97%	64%	0.074	0.989	0.34	0.99	-	-	0	0	100%	1
2OMI_RCO_A_301	90%	40%	0.093	0.978	1.07	1.31	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.